William Blair Issues Negative Estimate for Danaher Earnings

Danaher Co. (NYSE:DHR) – Equities researchers at William Blair cut their Q2 2025 earnings per share estimates for Danaher in a report issued on Thursday, January 30th. William Blair analyst M. Larew now anticipates that the conglomerate will post earnings of $1.82 per share for the quarter, down from their prior estimate of $1.92. The consensus estimate for Danaher’s current full-year earnings is $8.15 per share. William Blair also issued estimates for Danaher’s Q4 2025 earnings at $2.24 EPS, Q2 2026 earnings at $2.04 EPS, Q3 2026 earnings at $2.15 EPS, Q4 2026 earnings at $2.48 EPS and FY2026 earnings at $8.49 EPS.

Several other analysts have also recently commented on DHR. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Citigroup decreased their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday. TD Cowen increased their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a report on Thursday, October 31st. Finally, KeyCorp increased their target price on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Danaher Price Performance

Shares of NYSE:DHR opened at $222.56 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $235.66 and a 200 day moving average price of $253.24. Danaher has a 52 week low of $221.34 and a 52 week high of $281.70. The company has a market cap of $160.75 billion, a P/E ratio of 42.15, a PEG ratio of 4.22 and a beta of 0.83.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.72%. During the same period in the previous year, the firm posted $2.09 earnings per share.

Hedge Funds Weigh In On Danaher

A number of hedge funds have recently made changes to their positions in the stock. Coronation Fund Managers Ltd. raised its holdings in shares of Danaher by 29.9% during the 2nd quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after buying an additional 1,470 shares during the period. Quarry LP raised its stake in shares of Danaher by 250.6% in the 2nd quarter. Quarry LP now owns 298 shares of the conglomerate’s stock valued at $74,000 after purchasing an additional 213 shares in the last quarter. Cetera Investment Advisers grew its stake in Danaher by 6.5% in the second quarter. Cetera Investment Advisers now owns 130,209 shares of the conglomerate’s stock worth $32,533,000 after purchasing an additional 7,986 shares in the last quarter. Sanctuary Advisors LLC bought a new stake in Danaher in the second quarter valued at about $19,512,000. Finally, Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of Danaher by 21.4% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 45,434 shares of the conglomerate’s stock worth $11,352,000 after acquiring an additional 8,006 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.49%. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.